The new therapeutic approach in pleural mesothelioma involves targeting the tumor’s DNA repair mechanisms. By inhibiting specific DNA repair pathways, scientists aim to enhance the sensitivity of cancer cells to chemotherapy and radiotherapy. This approach disrupts the tumor’s ability to repair DNA damage caused by these treatments, potentially making them more effective against pleural mesothelioma. This novel strategy offers a promising avenue for improving treatment outcomes and patient responses in managing this challenging cancer.
